Overexpression of kallikrein 10 (hK10) in uterine serous papillary carcinomas
- 31 May 2006
- journal article
- Published by Elsevier in American Journal of Obstetrics and Gynecology
- Vol. 194 (5) , 1296-1302
- https://doi.org/10.1016/j.ajog.2005.10.794
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Gene expression fingerprint of uterine serous papillary carcinoma: identification of novel molecular markers for uterine serous cancer diagnosis and therapyBritish Journal of Cancer, 2005
- Overexpression of kallikrein 10 in epithelial ovarian carcinomasGynecologic Oncology, 2003
- Clear-cell and papillary serous cancer: treatment optionsBest Practice & Research Clinical Obstetrics & Gynaecology, 2001
- Extended Surgical Staging for Uterine Papillary Serous Carcinoma: Survival Outcome of Locoregional (Stage I–III) DiseaseGynecologic Oncology, 2001
- Preoperative CA 125 in endometrial cancer: Is it useful?American Journal of Obstetrics and Gynecology, 2000
- CA 125 may not reflect disease status in patients with uterine serous carcinomaCancer, 1998
- Uterine Papillary Serous Carcinoma: Patterns of Metastatic SpreadGynecologic Oncology, 1994
- Preoperative evaluation of serum CA 125, TAG 72, and CA 15-3 in patients with endometrial carcinomaAmerican Journal of Obstetrics and Gynecology, 1990
- Two pathogenetic types of endometrial carcinomaGynecologic Oncology, 1983
- Uterine papillary serous carcinomaThe American Journal of Surgical Pathology, 1982